Ab&B Bio-Tech's (HKG:2627) Chief Financial Officer Li Runxiang resigned effective Wednesday due to work adjustment, a same-day bourse filing showed.
The biotech company, on the same day, named Wu Jingyun as its new CFO, a Wednesday bourse filing showed.
Wu has also been nominated as an executive Director, subject to shareholder approval at the company's general meeting.
Trading in the company's shares, which was suspended April 1, remains suspended.